Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis.
A systematic review of research undertaken in vocational rehabilitation for people with multiple sclerosis.
Generic Midamor
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF.
Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
Multiple sclerosis.
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.
Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection-a case report.
Rituximab: Don't Count It Out as MS Treatment
Receptos, Inc. - Current Report: United States Securities and Exchange Commission Form 8-K
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study.
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.
A practical review of the neuropathology and neuroimaging of multiple sclerosis.
[A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis].
Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study.

Pages